F.D.A. Panel Is Split on Electroshock Risks - Wall Street Journal
A federal advisory panel was sharply divided on Friday about whether
to recommend that regulators designate electroshock devices as high risk.
FDA panel advises more testing of 'shock-therapy' devices - Washington Post
An expert panel advising the Food and Drug Administration decided
Friday that electroconvulsive therapy (ECT) machines should undergo
the same rigorous testing as new medical devices coming onto the
market - a decision that could drastically affect the future of
psychiatry's most controversial treatment.
Victory: FDA Panel Votes to Require Testing of ECT Device After
Survivors Testify at FDA Electroshock Hearing - MindFreedom
A panel for the US Food & Drug Administration voted to ask the FDA to
require testing of the device used for electroshock.
"People Who experience mood swings, fear, voices and visions"